Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,720 | $4,123 | $3,605 | $5,225 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Cost of Goods Sold | $3,538 | $2,598 | $2,143 | $2,421 |
| Gross Profit | $2,182 | $1,524 | $1,462 | $2,804 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $324 | $256 | $202 | $199 |
| SG&A Expenses | $533 | $401 | $359 | $317 |
| Sales & Mktg Exp. | $209 | $145 | $158 | $118 |
| Other Operating Expenses | $434 | $385 | $270 | $225 |
| Operating Expenses | $967 | $787 | $630 | $542 |
| Operating Income | $1,214 | $738 | $832 | $2,262 |
| % Margin | 21.2% | 17.9% | 23.1% | 43.3% |
| Other Income/Exp. Net | $225 | -$0 | $21 | -$30 |
| Pre-Tax Income | $1,440 | $737 | $854 | $2,232 |
| Tax Expense | $431 | $269 | $327 | $740 |
| Net Income | $1,077 | $510 | $541 | $1,413 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| Weighted Avg Shares Out | 594 | 600 | 600 | 600 |
| Weighted Avg Shares Out Dil | 594 | 600 | 600 | 600 |
| Supplemental Information | – | – | – | – |
| Interest Income | $145 | $53 | $95 | $113 |
| Interest Expense | $171 | $142 | $123 | $98 |
| Depreciation & Amortization | $483 | $401 | $317 | $239 |
| EBITDA | $2,093 | $1,280 | $1,294 | $2,569 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |